Welcome, Guest. Please login or register.
July 17, 2024, 05:35:25 am

Login with username, password and session length

  • Total Posts: 55130
  • Total Topics: 4851
  • Online Today: 219
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 26
Total: 26


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: In Very Rare Cases, Some Hep C May Remain After a Cure  (Read 6092 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
In Very Rare Cases, Some Hep C May Remain After a Cure
« on: October 18, 2019, 10:45:36 am »
In extremely rare instances, people with HIV who have ostensibly been cured of hepatitis C virus (HCV) may retain very low levels of the virus for some time afterward, aidsmap reports. However, such persistent virus has not been tied to liver damage.

Publishing their findings in Nature Scientific Reports, a research team led by Antonio Rivero-Juárez, MD, of Unidad de Enfermedades Infecciosas in Córdoba, Spain, conducted a prospective longitudinal study of 123 people with HIV and HCV coinfection who were treated for hep C between 2015 and 2018 at hospitals in the Andalusia region of Spain.

All participants had achieved a sustained virologic response—an undetectable hep C viral load—24 weeks after completing therapy, which is known as an SVR24 and is considered a cure. More than 12 months had passed since all achieved this benchmark.



© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.